|
page 1/28
|
| |
|
|
|
|
|
Bone A, Guthmann JP, Assal A, ROUSSET D, Degeorges A, Morel P, Valette M, Enouf V, Jacquot E, Pelletier B, Le Strat Y, Pillonel J, Fonteneau L, van der Werf S, Lina B, Tiberghien P, Levy-Bruhl D. Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France. PLoS One. 2012;7:e33056. Thèmes : Autres virus ; maj-2012-11

|
|
|
|
|
|
|
|
|
Delwart E. Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? Transfusion. 2012;52:1398-1403. Thèmes : Autres virus ; maj-2012-11

|
|
|
|
|
Dodd RY, Hackett J Jr, Linnen JM, Dorsey K, Wu Y, Zou S, Qiu X, Swanson P, Schochetman G, Gao K, Carrick JM, Krysztof DE, Stramer SL. Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety. Transfusion. 2012;52:298-306. Thèmes : Autres virus ; maj-2012-11

|
|
|
|
|
|
|
|
|
Geraudie B, Charrier M, Bonnafous P, Heurte D, Desmonet M, Bartoletti MA, Penasse C, Agut H, Gautheret-Dejean A. Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors. J Clin Virol. 2012;53:151-155. Thèmes : Autres virus ; maj-2012-11

|
|
|
|
|
|
|
|
|
|
|
Karafin MS, Stramer SL. The scientific method at work: xenotropic murine leukemia virus-related virus is neither a cause of chronic fatigue syndrome nor a threat to the blood supply. Transfusion. 2012;52:222-225. Thèmes : Autres virus ; maj-2012-11

|
|
|
|
|
|
|
Kreil TR, Mc Vey JK, Lei LS, Camacho L, Wodal W, Kerschbaum A, Segura E, Vandamme E, Gavit P, Ehrlich HJ, Barrett PN, Baker DA. Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza. Transfusion. 2012;52:803-809. Thèmes : Plasma et dérivés plasmatiques ; Autres virus ; maj-2012-11

|
|
|
|
|
|
|
|
|
|
|
page 1/28
|